ResearcherUniversity of KentuckyNo recent work listed

Thomas Amburn

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1544-9954; OpenAlex author ID A5003386184. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

New Cancer-Related Symptoms Predict Recurrence in CA19-9 Non-Expressers After Resection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/00031348221117031 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael J. Cavnar · 1 shared paper, 2023 · strength 0.20
- Paper New Cancer-Related Symptoms Predict Recurrence in CA19-9 Non-Expressers After Resection of Pancreatic Ductal Adenocarci… DOI 10.1177/00031348221117031 ↗
Reema Anil Patel · 1 shared paper, 2023 · strength 0.20
- Paper New Cancer-Related Symptoms Predict Recurrence in CA19-9 Non-Expressers After Resection of Pancreatic Ductal Adenocarci… DOI 10.1177/00031348221117031 ↗
Joseph Kim · 1 shared paper, 2023 · strength 0.20
- Paper New Cancer-Related Symptoms Predict Recurrence in CA19-9 Non-Expressers After Resection of Pancreatic Ductal Adenocarci… DOI 10.1177/00031348221117031 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.